Peter Cheverton

BEAM: A Randomized Phase II Study Evaluating the Activity of Bevacizumab in Combination With Carboplatin Plus Paclitaxel in Patients With Previously Untreated Advanced Melanoma

Kevin B. Kim, Jeffrey A. Sosman, John P. Fruehauf et al. · Journal of Clinical Oncology · 2011 · 196 citations · Full text

Prospective randomized trial of combined oncological therapy for gastric carcinoma

D M Dent, I. D. Werner, Ben Novis et al. · Cancer · 1979 · 115 citations · Full text

Phase I and Pharmacokinetic Study of DE-310 in Patients with Advanced Solid Tumors

Otto Soepenberg, Maja J.A. de Jonge, Alex Sparreboom et al. · Clinical Cancer Research · 2005 · 73 citations · Full text

Phase I and pharmacokinetic study of TZT-1027, a novel synthetic dolastatin 10 derivative, administered as a 1-hour intravenous infusion every 3 weeks in patients with advanced refractory cancer

Patrick Schöffski, B. Thate, Gernot Beutel et al. · Annals of Oncology · 2004 · 66 citations · Full text

1-Hour Intravenous Infusion, Medicine, Pharmacology +7

Phase III results of exatecan (DX-8951f) versus gemcitabine (Gem) in chemotherapy-naïve patients with advanced pancreatic cancer (APC)

Peter Cheverton, Csilla András, Tomáš Šálek et al. · Journal of Clinical Oncology · 2004 · 54 citations

Chemotherapy-naïve Patients, Cancer Management, Pathology +18